DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sugimoto K, Kim SR, Kim SK. , et al.
Comparison of daclatasvir and asunaprevir for chronic HCV 1b infection with telaprevir and simeprevir plus peginterferon and ribavirin, with a focus on the prevention of occurrence and recurrence of hepatocellular carcinoma.
Oncology 2015;
89 (Suppl. 02) 42-46
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.